SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000899866-21-000061
Filing Date
2021-07-20
Accepted
2021-07-20 08:20:50
Documents
12
Period of Report
2021-07-20
Items
Item 2.02: Results of Operations and Financial Condition

Document Format Files

Seq Description Document Type Size
1 8-K alxn-20210720.htm   iXBRL 8-K 51146
  Complete submission text file 0000899866-21-000061.txt   188318

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT alxn-20210720.xsd EX-101.SCH 1943
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT alxn-20210720_lab.xml EX-101.LAB 24275
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT alxn-20210720_pre.xml EX-101.PRE 12677
5 EXTRACTED XBRL INSTANCE DOCUMENT alxn-20210720_htm.xml XML 10827
Mailing Address 121 SEAPORT BOULEVARD BOSTON MA 02210
Business Address 121 SEAPORT BOULEVARD BOSTON MA 02210 4752302596
ALEXION PHARMACEUTICALS, INC. (Filer) CIK: 0000899866 (see all company filings)

IRS No.: 133648318 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-27756 | Film No.: 211099519
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences